Anqi Zhou

机构：Liaocheng University, Peking University, National Medical Products Administration, Wenzhou Medical University, Shanghai Innovative Research Center of Traditional Chinese Medicine, Soochow University, Institute of Macromolecular Chemistry, First Affiliated Hospital of Soochow University · ORCID：0000-0001-9358-3054

发表论文 54 篇 · 总被引 662 次 · h-index 15

代表论文

• Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein (2024 · Signal Transduction and Targeted Therapy · 被引 28)
• Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study (2025 · The Lancet Respiratory Medicine · 被引 17)
• Restaurant survival prediction using machine learning: Do the variance and sources of customers’ online reviews matter? (2024 · Tourism Management · 被引 15)
• Hierarchical porous carbon nanofibrous membranes with elaborated chemical surfaces for efficient adsorptive removal of volatile organic compounds from air (2024 · Journal of Colloid and Interface Science · 被引 15)
• Neural mechanism of the sexually dimorphic winner effect in mice (2025 · Neuron · 被引 7)
• Construction of Minigenome Replicon of Nipah Virus and Investigation of Biological Activity (2025 · Viruses · 被引 7)